Clinical StudyNormal or non-diagnostic neuroimaging studies prior to the detection of malignant primary brain tumors
Introduction
With increasing access to advanced neuroimaging techniques in Emergency Departments (ED), contrast-enhanced CT scans and MRI are often performed to investigate new neurologic complaints within days or even hours of onset. Confusion arises when such studies are normal or reveal non-specific abnormalities despite overt symptoms or signs. Patients are often perplexed when later studies reveal abnormalities typical for aggressive, malignant neoplasms.
Section snippets
Materials and methods
As part of a specialty neuro-oncology service, the neurosurgeon (M.S.) and the neuro-oncologist (A.D.) retrospectively identified 17 patients with a malignant primary brain tumor with non-diagnostic neuroimaging (CT scan or MRI) from a total cohort of consecutive, newly diagnosed patients with a malignant brain tumor treated between 1 July 2006 and 30 June 2008. Data on clinical characteristics were gathered by a retrospective review of patients’ charts. A neuroradiologist (K.B.) re-reviewed
Results
Of the 193 newly diagnosed, consecutive patients with brain tumors diagnosed between 1 July 2006 and 30 June 2008, 102 patients had World Health Organization (WHO) grade IV gliomas (glioblastoma multiforme, GBM), 18 had low grade gliomas (LGG), 54 had anaplastic gliomas (AG), and 19 had primary central nervous system lymphomas (PCNSL). No patients with LGG or AG had a history of normal neuroimaging. Normal neuroimaging was found in eight of 102 patients with GBM (8%) and one of 19 patients with
Discussion
This retrospective study carries significant risk for recollection bias. To minimize such risks, we included all consecutive malignant primary brain tumor patients diagnosed by us at a single institution within a specified two year period. In addition, patients who reported normal neuroimaging studies that could not be verified were included in the total patient number, but excluded as neuroimaging failures. However, a much larger study than our 193 patients is needed to accurately predict
Conclusions
Patients who have normal brain CT scans or MRI after an accident, or because of new neurological symptoms, may prove to have high grade gliomas upon repeat imaging done months or years after the initial studies. If non-specific abnormalities are seen on T2-weighted MRI alone, follow-up imaging should be done within, at most, three months.
References (6)
- et al.
Genetic pathways to glioblastoma: a population-based study
Cancer Res
(2004) - et al.
Age-dependent prognostic effects of genetic alterations in glioblastoma
Clin Cancer Res
(2004) - et al.
Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers
JAMA
(1999)
Cited by (13)
Cortical T2-hyperintense lesions as the initial MRI finding in glioblastoma
2021, Interdisciplinary Neurosurgery: Advanced Techniques and Case ManagementCitation Excerpt :Were it not for this finding, the focal cortical hyperintensity could have potentially been misinterpreted and lengthened the interval to gross total resection. Review of retrospective literature suggests that nearly 10% of GBM patients may have associated early lesions on imaging [2,4,5,13]. These are typically T2-hyperintense abnormalities not selectively involving grey or white matter, and include varying degrees of diffusion restriction or contrast enhancement.
Screening for brain cancer: Why (Not): Letter
2014, World NeurosurgeryImaging Spectrum of the Developing Glioblastoma: A Cross-Sectional Observation Study
2023, Current OncologyUpfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literature
2022, Neuro-Oncology Advances